IVD MEDICAL (01931): Tai Yang, previously an independent non-executive director, has been reassigned as an executive director.
Huajian Medical (01931) announced that Ms. Tai Yang has been appointed as an executive director of the company, transitioning from an independent non-executive director, effective from 2...
IVD MEDICAL (01931) Announcement: Ms. Tai Yang has been reassigned from an independent non-executive director to an executive director of the company, effective from October 20, 2025.
In light of the reassignment, the following changes to the Board of Directors took effect from October 20, 2025:
1. Ms. Tai Yang is no longer a member of the Remuneration Committee, and Mr. Zhang Jianlei has been appointed as a member of the Remuneration Committee; and
2. Ms. Tai Yang has resigned as the Chairman of the Nomination Committee, but will continue to serve as a member of the Nomination Committee, while Mr. Zhang Jianlei has been appointed as the Chairman of the Nomination Committee.
Related Articles

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


